Under the settlement agreement, plaintiffs dropped their claim for a substantial monetary recovery. In exchange, Meade has agreed to pay a de minimus amount to the plaintiffs and to rename their ground breaking RCX product, not using any initials that might suggest Ritchey-Chretien in the name.
At the same time, Meade will be under no restrictions in referencing the Ritchey-Chretien-like benefits of the RCX product, such as the elimination of coma, which many people feel is the single largest benefit of the Ritchey-Chretien optical system.
For comments and feedback: contact editorial@rttnews.com Copyright(c) 2008 RealTimeTraders.com, Inc. All Rights Reserved

More News:
Market Updates |
Stock Alerts |
All Trading News |
Stock Index